NCT01880749View on ClinicalTrials.gov

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Neurofibromatosis Type 2Vestibular SchwannomasMeningiomas
Interventions
DRUG

RAD001

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01880749 - Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas | Biotech Hunter | Biotech Hunter